List of selected Publications<\/p>\n
Park JY, Sunga O, Wanitphakdeedecha R, Frevert J. Neurotoxin Impurities: A Review of Threats to Efficacy. Plast Reconstr Surg Glob Open. 2020 Jan 24;8(1):e2627.<\/p>\n
Kerscher M, Wanitphakdeedecha R, Trindade de Almeida A, Maas C, Frevert J. IncobotulinumtoxinA: A Highly Purified and Precisely Manufactured Botulinum Neurotoxin Type A. J Drugs Dermatol. 2019 Jan 1;18(1):52-57<\/p>\n
Frevert J, Ahn KY, Park MY, Sunga O. Comparison of botulinum neurotoxin type A formulations in Asia. Clin Cosmet Investig Dermatol. 2018 Jul 5;11:327-331<\/p>\n
L\u00f3pez de la Paz M, Scheps D, Jurk M, Hofmann F, Frevert J. Rational design of botulinum neurotoxin A1 mutants with improved oxidative stability. Toxicon. 2018 Jun 1;147:54-57<\/p>\n
Frevert J. Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products. Drugs R D. 2015 Mar;15(1):1-9<\/p>\n
Frevert J. Content of botulinum neurotoxin in Botox\u00ae\/Vistabel\u00ae, Dysport\u00ae\/Azzalure\u00ae, and Xeomin\u00ae\/Bocouture\u00ae. Drugs R D. 2010;10(2):67-73<\/p>\n
Bigalke H, Frevert J. Botulinum toxin A: dose and immune response. Int J Rehabil Res. 2012 Jun;35(2):93<\/p>\n
Frevert J, Dressler D. Complexing proteins in botulinum toxin type A drugs: a help or a hindrance? Biologics. 2010 Dec 9;4:325-32<\/p>\n
Frevert J. Xeomin is free from complexing proteins. Toxicon. 2009 Oct;54(5):697-701<\/p>\n
Heinemann U, Frevert J, Hofmann K, Illing G, Maurer C, Oschkinat H, Saenger W. An integrated approach to structural genomics. Prog Biophys Mol Biol. 2000;73(5):347-62<\/p>\n
Salas JA, Rohr J. The Novel Hybrid Antitumor Compound Premithramycinone H Provides Indirect Evidence for a Tricyclic Intermediate of the Biosynthesis of the Aureolic Acid Antibiotic Mithramycin. Angew Chem Int Ed Engl. 2000 Feb;39(4):796-799<\/p>\n
Abreu PM, Martins ES, Kayser O, Bindseil KU, Siems K, Seemann A, Frevert J. Antimicrobial, antitumor and antileishmania screening of medicinal plants from Guinea-Bissau. Phytomedicine. 1999 Jul;6(3):187-95<\/p>\n
G\u00f6schel H, Wohlfarth K, Frevert J, Dengler R, Bigalke H. Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies–therapeutic consequences. Exp Neurol. 1997 Sep;147(1):96-102<\/p>\n
Wohlfarth K, G\u00f6schel H, Frevert J, Dengler R, Bigalke H. Botulinum A toxins: units versus units. Naunyn Schmiedebergs Arch Pharmacol. 1997 Mar;355(3):335-40<\/p>\n
Erdal E, Bartels F, Binscheck T, Erdmann G, Frevert J, Kistner A, Weller U, Wever J, Bigalke H. Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells. Naunyn Schmiedebergs Arch Pharmacol. 1995 Jan;351(1):67-78<\/p>\n
Bartels F, Bergel H, Bigalke H, Frevert J, Halpern J, Middlebrook J. Specific antibodies against the Zn(2+)-binding domain of clostridial neurotoxins restore exocytosis in chromaffin cells treated with tetanus or botulinum A neurotoxin. J Biol Chem. 1994 Mar 18;269(11):8122-7<\/p>\n
Maier K, Ehrhardt G, Frevert J. Antibacterial activity of cultured human keratinocytes. Arch Dermatol Res. 1992;284(2):119-21<\/p>\n
Spranz E, Siegemund B, Frevert J, Knoell HE. Study on the penetration of tetanus toxoid through the nasal mucosa. Arch Toxicol Suppl. 1991;14:276-9<\/p>\n
Binz T, Kurazono H, Wille M, Frevert J, Wernars K, Niemann H. The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins. J Biol Chem. 1990 Jun
\n5;265(16):9153-8 mucosa. Arch Toxicol Suppl. 1991;14:276-9<\/p>\n
Bette P, Frevert J, Mauler F, Suttorp N, Habermann E. Pharmacological and biochemical studies of cytotoxicity of Clostridium novyi type A alpha-toxin. Infect Immun. 1989 Aug;57(8):2507-13<\/p>\n
Aktories K, Frevert J. ADP-ribosylation of a 21-24 kDa eukaryotic protein(s) by C3, a novel botulinum ADP-ribosyltransferase, is regulated by guanine nucleotide. Biochem J. 1987 Oct 15;247(2):363-8<\/p>\n
Frevert J, Ballou CE. Saccharomyces cerevisiae structural cell wall mannoprotein. Biochemistry. 1985 Jan 29;24(3):753-9<\/p>\n
Tsai PK, Frevert J, Ballou CE. Carbohydrate structure of Saccharomyces cerevisiae mnn9 mannoprotein. J Biol Chem. 1984 Mar 25;259(6):3805-11<\/p>\n
Frevert J, Ballou CE. Yeast invertase polymorphism is correlated with variable states of oligosaccharide chain phosphorylation. Proc Natl Acad Sci U S A. 1982 Oct;79(20):6147-50<\/p>\n
Frevert J, K\u00f6ller W, Kindl H. Occurrence and biosynthesis of glyoxysomal enzymes in ripening cucumber seeds. Hoppe Seylers Z Physiol Chem. 1980 Oct;361(10):1557-65<\/p>\n
Frevert J, Kindl H. Purification of glyoxysomal acetyl-CoA acyltransferase. Hoppe Seylers Z Physiol Chem. 1980 Apr;361(4):537-42<\/p>\n
Frevert J, Kindl H. A bifunctional enzyme from glyoxysomes. Purification of a protein possessing enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase activities. Eur J Biochem.
\n1980;107(1):79-86<\/p>\n
Kindl H, K\u00f6ller W, Frevert J. Cytosolic precursor pools during glyoxysome biosynthesis. Hoppe Seylers Z Physiol Chem. 1980;361(3):465-7<\/p>\n
K\u00f6ller W, Frevert J, Kindl H. Albumins, glyoxysomal enzymes and globulins in dry seeds of cucumis sativus: qualitative and quantitative analysis. Hoppe Seylers Z Physiol Chem. 1979 Feb;360(2):167-76<\/p>\n
Frevert J, Kindl H. Plant microbody proteins. Purification and glycoprotein nature of glyoxysomal isocitrate lyase from cucumber cotyledons. Eur J Biochem. 1978 Dec 1;92(1):35-43<\/p>","protected":false},"excerpt":{"rendered":"
List of selected Publications<\/p>\n","protected":false},"author":2,"featured_media":27308,"parent":30428,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-full-width.php","meta":{"_acf_changed":false,"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"class_list":["post-11358","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/11358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/comments?post=11358"}],"version-history":[{"count":1,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/11358\/revisions"}],"predecessor-version":[{"id":30459,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/11358\/revisions\/30459"}],"up":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/30428"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/media\/27308"}],"wp:attachment":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/media?parent=11358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}